FGF9 and osteosarcoma: The contribution of FGF9 to osteosarcoma risk could also stem from its role in angiogenesis associated with long bone growth and repair [36]; or could be due to altered expression in the hypothalamus [37], which, in concert with the pituitary, is a master regulator of long bone growth [38].